KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Receivables - Net (2016 - 2025)

Historic Receivables - Net for Novartis Ag (NVS) over the last 13 years, with Q4 2025 value amounting to $8.9 billion.

  • Novartis Ag's Receivables - Net rose 2039.61% to $8.9 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $8.9 billion, marking a year-over-year increase of 2039.61%. This contributed to the annual value of $8.9 billion for FY2025, which is 2039.61% up from last year.
  • As of Q4 2025, Novartis Ag's Receivables - Net stood at $8.9 billion, which was up 2039.61% from $7.4 billion recorded in Q4 2024.
  • Over the past 5 years, Novartis Ag's Receivables - Net peaked at $9.2 billion during Q2 2023, and registered a low of $7.1 billion during Q4 2023.
  • Over the past 5 years, Novartis Ag's median Receivables - Net value was $8.2 billion (recorded in 2021), while the average stood at $8.2 billion.
  • In the last 5 years, Novartis Ag's Receivables - Net crashed by 1188.94% in 2023 and then skyrocketed by 2039.61% in 2025.
  • Quarter analysis of 5 years shows Novartis Ag's Receivables - Net stood at $8.0 billion in 2021, then grew by 0.76% to $8.1 billion in 2022, then decreased by 11.89% to $7.1 billion in 2023, then increased by 4.45% to $7.4 billion in 2024, then rose by 20.4% to $8.9 billion in 2025.
  • Its last three reported values are $8.9 billion in Q4 2025, $7.4 billion for Q4 2024, and $7.1 billion during Q4 2023.